Targeted therapy for osteosarcoma: a review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted therapy for osteosarcoma: a review

Published:2023-02-18 Issue:9 Volume:149 Page:6785-6797
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Li Shizhe,Zhang He,Liu Jinxin,Shang Guanning

Funder

China Postdoctoral Science Foundation

345 Talent Project of Shengjing Hospital

Shenyang Science and Technology Project

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04614-4.pdf

Reference128 articles.

1. Alexander JH, Binitie OT, Letson GD et al (2021) Osteosarcoma: an evolving understanding of a complex disease. J Am Acad Orthop Surg 29(20):e993–e1004

2. Ameline B, Kovac M, Nathrath M et al (2021) Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target? J Pathol Clin Res 7(2):165–172

3. Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22(10):1276–1312

4. Assi T, Watson S, Samra B et al (2021) Targeting the VEGF pathway in osteosarcoma. Cells 10(5):1240

5. Belayneh R, Fourman MS, Bhogal S et al (2021) Update on osteosarcoma. Curr Oncol Rep 23(6):71

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Groenlandicine enhances cisplatin sensitivity in cisplatin-resistant osteosarcoma cells through the BAX/Bcl-2/Caspase-9/Caspase-3 pathway;Journal of Bone Oncology;2024-10

2. LncRNA HOXA-AS3 promotes cell proliferation and invasion via targeting miR-218-5p/FOXP1 axis in osteosarcoma;Scientific Reports;2024-07-17

3. Recent progress in diagnostic imaging and therapeutics of osteosarcoma based on multifunctional nanoparticles;Science China Chemistry;2024-07-11

4. Advances in the anti-tumor mechanisms of saikosaponin D;Pharmacological Reports;2024-07-04

5. Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics;Pathology - Research and Practice;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3